| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K52037352 |
| PharmacoGx | BRD-K52037352 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FLRT1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | PROP1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | DUSP3 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | LACC1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | RHBDD2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | U2AF1L4 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | EVC | CTRPv2 | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | SLC19A1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | NPRL3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | KLHL5 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.04 |
